Patents by Inventor VANDERBILT UNIVERSITY
VANDERBILT UNIVERSITY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140044673Abstract: The present invention provides for a mass spectrometry proteomic approach to distinguishing Spitz nevi from Spitzoid malignant melanoma. Histology directed mass spectral profiling allows for targeted analysis of sites of melanocytic lesion within formalin-fixed, paraffin embedded excisional biopsies. The classification system identified 5 peptide peaks, of which two have been identified as originating from vimentin and actin. A sensitivity and specificity for Spitz nevi of 97% and 90%, respectively, were achieved.Type: ApplicationFiled: February 1, 2013Publication date: February 13, 2014Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY
-
Publication number: 20130296851Abstract: One aspect of the present disclosure includes a catheter. The catheter includes a catheter body having a temperature-controlled anchor element thereon that is configured to attach the catheter body to tissue by forming a congealed adherence layer between the anchor element and the tissue. The catheter also includes an ablation element connected to the catheter body. The ablation element is axially spaced apart from the anchor element. The ablation element is configured to ablate tissue when the anchor element is attached to the tissue.Type: ApplicationFiled: April 12, 2013Publication date: November 7, 2013Inventor: Vanderbilt University
-
Publication number: 20130217917Abstract: A method of making a betaine aldehyde, comprising ozonizing an allyl trimethylammonium to form the betaine aldehyde.Type: ApplicationFiled: March 27, 2013Publication date: August 22, 2013Applicant: VANDERBILT UNIVERSITYInventor: Vanderbilt University
-
Publication number: 20130217952Abstract: A flexible endoscope for ophthalmic orbital surgery includes a flexible probe housing having a proximal end, a distal end and a lumen extending between the proximal end and the distal end. The endoscope also includes an image fiber disposed in the lumen that communicates image information from the distal end of the flexible probe, a purge fluid/gas port disposed at the proximal end of the flexible probe that accepts purge fluid/gas and a purge fluid/gas conduit disposed in the lumen and in fluid communication with the purge fluid/gas port. The fluid/gas conduit delivers purge fluid/gas to the distal end of the endoscope. The endoscope also includes an access conduit disposed in the lumen that receives one of an ablation instrument, a coagulating instrument and a medication delivery instrument.Type: ApplicationFiled: March 21, 2013Publication date: August 22, 2013Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY
-
Publication number: 20130210021Abstract: Disclosed is an isolated strain of a previously unknown Staphylococcus, Staphylococcus pseudolugdunensis. Also disclosed are the sequences of the S. pseudolugdunensis tuf gene and 16s rRNA and methods for distinguishing S. pseudolugdunensis from other staphylococcal species.Type: ApplicationFiled: April 12, 2013Publication date: August 15, 2013Applicants: Qiagen Sciences, Inc., Vanderbilt UniversityInventors: Vanderbilt University, Qiagen Sciences, Inc.
-
Publication number: 20130208235Abstract: A low-vision reader for individuals with low vision, includes a frame for supporting lenses, at least one oculus dexter lens supported by the frame on an oculus dexter side, and at least one oculus sinister lens supported by the frame on an oculus sinister side, and a pair of lights. Each of the lenses has an induced prism in a range between about 0 PD and about 22 PD and a lens power that is greater than about +4.00 diopters and less than +20.00 diopters such that each of the said lenses focused at a distance that is greater than about 5 cm and less than about 25 cm. Each light has a predetermined light strength is mounted adjacent the outer portions of the lenses and oriented to project light to provide a predetermined overlapping lighted area in a predetermined field.Type: ApplicationFiled: March 21, 2013Publication date: August 15, 2013Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY
-
Publication number: 20130180235Abstract: The invention is a combination accumulator and reservoir which stores energy when the accumulator deforms from its original shape in response to the flow of a pressurized fluid from the reservoir. The stored energy is returned when the fluid flow is reversed and the accumulator discharges the fluid and returns to its original shape. At least one part of the novelty of the invention is that the accumulator and the fluid reservoir reside in the same housing such that the volume of each varies inversely. Accordingly, the invention is more compact and weighs less than conventional accumulators. Another feature of the invention is that fluid is located around the bladder accumulator to lubricate contact between the bladder and sides of the reservoir.Type: ApplicationFiled: March 10, 2013Publication date: July 18, 2013Applicant: VANDERBILT UNIVERSITYInventor: Vanderbilt University
-
Publication number: 20130177502Abstract: Compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. Compounds and methods demonstrated pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, cellular proliferation imaging as targeted agents that incorporate signaling agents.Type: ApplicationFiled: February 12, 2013Publication date: July 11, 2013Applicant: VANDERBILT UNIVERSITYInventor: Vanderbilt University
-
Publication number: 20130178458Abstract: In one aspect, the invention relates to substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs, derivatives thereof, and related compounds, which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.Type: ApplicationFiled: December 3, 2012Publication date: July 11, 2013Applicant: Vanderbilt UniversityInventor: Vanderbilt University
-
Publication number: 20130171144Abstract: The present invention relates to compositions and methods for inhibiting thrombosis without compromising hemostasis. Compositions include anti-factor XI monoclonal antibodies (aXIMabs) capable of binding to an epitope on the heavy chain of human FXI, particularly the A3 domain of the heavy chain of human FXI. Compositions also include epitope-binding fragments, variants, and derivatives of the monoclonal antibodies, cell lines producing these antibody compositions, and isolated nucleic acid molecules encoding the amino acid sequences of the antibodies. The invention further includes pharmaceutical compositions comprising the anti-factor XI monoclonal antibodies of the invention, or epitope-binding fragments, variants, or derivatives thereof, in a pharmaceutically acceptable carrier.Type: ApplicationFiled: March 4, 2013Publication date: July 4, 2013Applicants: VANDERBILT UNIVERSITY, OREGON HEALTH & SCIENCE UNIVERSITYInventors: OREGON HEALTH & SCIENCE UNIVERSITY, VANDERBILT UNIVERSITY
-
System and Methods of Using Image-Guidance for Providing an Access to a Cochlear of a Living Subject
Publication number: 20130165960Abstract: A system and methods for providing an access to a cochlea of a living subject. In one embodiment of the present invention, a method comprises the steps of operating a surgical instrument towards a region of interest of the living subject for opening an access to the cochlea of the living subject from the lateral edge of the skull of the living subject to the cochlea of the living subject, and intra-operatively monitoring at least a part of the surgical instrument so that the surgical instrument is operated substantially along a predetermined path.Type: ApplicationFiled: February 18, 2013Publication date: June 27, 2013Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY -
Publication number: 20130143165Abstract: A micro-mirror well. In one embodiment the micro-mirror well includes a plurality of planar mirrors arranged around an axis of symmetry and inclined to form a pyramid well, where each of the plurality of planar mirrors is capable of reflecting light emitting from an object of interest placed inside the pyramid well.Type: ApplicationFiled: November 27, 2012Publication date: June 6, 2013Applicant: VANDERBILT UNIVERSITYInventor: Vanderbilt University
-
Publication number: 20130123236Abstract: In one aspect, the invention relates to substituted benzylspiroindolin-2-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M1 (mAChR M1); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.Type: ApplicationFiled: November 10, 2012Publication date: May 16, 2013Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY
-
Publication number: 20130089528Abstract: Nuclear Transport Modifiers such as cSN50 and cSN50.1, afford in vivo islet protection following a 2-day course of intense treatment in autoimmune diabetes-prone, non-obese diabetic (NOD) mice, a widely used model of Type 1 diabetes (T1D), which resulted in a diabetes-free state for one year without apparent toxicity and the need to use insulin. cSN50 precipitously reduces the accumulation of islet-destructive autoreactive lymphocytes while enhancing activation-induced cell death of T and B lymphocytes derived from NOD mice. cSN50 attenuated pro-inflammatory cytokine and chemokine production in immune cells in this model of human T1D. cSN50 also provides cytoprotection of beta cells, therefore preserving residual insulin-producing capacity. Because intracellular delivery of a Nuclear Transport Modifier peptide such as cSN50 and cSN50.Type: ApplicationFiled: October 5, 2012Publication date: April 11, 2013Applicant: VANDERBILT UNIVERSITYInventor: Vanderbilt University
-
Publication number: 20130063434Abstract: A method and system of compensation for intra-operative organ shift of a living subject usable in image guide surgery. In one embodiment, the method includes the steps of generating a first geometric surface of the organ of the living subject from intra-operatively acquired images of the organ of the living subject, constructing an atlas of organ deformations of the living subject from pre-operatively acquired organ images from the pre-operatively acquired organ images, generating a second geometric surface of the organ from the atlas of organ deformations, aligning the second geometric surface of the organ to the first geometric surface of the organ of the living subject to determine at least one difference between a point of the first geometric surface and a corresponding point of the second geometric surface of the organ of the living subject, which is related to organ shift, and compensating for the intra-operative organ shift.Type: ApplicationFiled: November 1, 2012Publication date: March 14, 2013Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY
-
Publication number: 20130065929Abstract: Methods for treating and/or preventing at least one symptom of a disorder associated with oxidative stress, carbonyl stress, or combinations thereof in a subject. In some embodiments, the methods include administering to the subject an effective amount of pyridoxamine, an analog or derivative thereof, or a pharmaceutically acceptable salt of any of the foregoing. Also provided are methods for treating or preventing a nephropathy, acute renal injury, acute renal failure, or combinations thereof in a subject, and formulations adapted for intravenous administration comprising pyridoxamine, an analog or derivative thereof, or a pharmaceutically acceptable salt of any of the foregoing.Type: ApplicationFiled: October 24, 2012Publication date: March 14, 2013Applicant: VANDERBILT UNIVERSITYInventor: VANDERBILT UNIVERSITY